Health execs persevere in new policy landscape
Despite a prolonged period of policy uncertainty in the U.S.—and the ripple effects across the global life sciences and healthcare industries—executives at health companies are still seeing opportunit...
15 Touko 22min
Revisiting Pharma’s tariff reality
After months of mixed messaging from the White House, the pharmaceutical industry has gained more clarity on the second Trump administration’s import tariff policy for drugs. While many of the industr...
8 Touko 15min
Setting a new standard in prefillable syringe systems (Sponsored)
In this sponsored episode of The Top Line, host Kelly Hogan speaks with Dr. Bettine Boltres, director of scientific affairs, integrated systems at West Pharmaceutical Services, about the development o...
7 Touko 12min
Scaling theranostics through access, safety and trust (Sponsored)
Theranostics is transforming cancer care, but scaling these treatments requires overcoming operational and workforce challenges. In this episode of The Top Line, Curium’s Mike Patterson discusses how ...
4 Touko 7min
A pivotal time for an RNA pioneer
It’s a pivotal year for RNA therapeutics pioneer Ionis Pharmaceuticals. After transitioning from a partnering model to a full-ownership strategy following the 2024 approval of Tryngolza, the company ...
1 Touko 35min
Accelerating clinical trials with precision logistics (Sponsored)
Speed, precision, and visibility are critical to clinical trial success, and logistics plays a central role in delivering all three. In this interview, Manishaa O’Brien, director of commercial operati...
27 Huhti 7min
Can Trump’s deal with the UK become a model for similar drug price agreements?
President Donald Trump has struck a deal with the UK that exempts prescription drugs imported to the United States from tariffs for three years. In exchange, Britain’s National Health Service will pay...
24 Huhti 21min
Biomarkers are reshaping oncology trial design (Sponsored)
Biomarkers are playing an increasingly critical role in shaping the future of oncology trials—and the pace of innovation is accelerating. In this sponsored episode of The Top Line, host Stephanie Butl...
21 Huhti 14min
